Table 1.
Demographic and clinical data.
| Group A | Group B | Group C | |
| Cases | 102 (104 eyes) | 117 (120 eyes) | 109 (111 eyes) |
| Sex (male: female) | 54:48 | 59:58 | 52:57 |
| Age, y | 56.2 ± 16.5 | 54.9 ± 17.9 | 58.6 ± 19.4 |
| Range | 5–72 | 4M-69 | 2–75 |
| BCVA | FC-0.4 | NLP-0.5 | 0.05–0.4 |
| IOP, mmHg | 35.5 ± 8.4 | 36.2 ± 7.6 | 34.3 ± 8.6 |
| Glaucoma medications | 3.26 ± 1.55 | 3.15 ± 1.98 | 3.44 ± 1.64 |
| Glaucoma type (eyes) | |||
| NVG | 29 cases (30 eyes) | 34 cases (35 eyes) | 31 cases (31eyes) |
| Intravitreal injection (Lusentis) 24 | 28 | 28 | |
| Hyphema | 5 | 6 | 4 |
| After trauma surgery | 12 | 15 | 13 |
| After vitrectomy | 24 | 28 | 27 |
| After glaucoma surgery | 29 | 32 | 29 |
| other | 9 | 10 | 11 |
| FP7:FP8 | 104:0 | 118:2 | 111:1 |
| Operation site | |||
| (Superotemporal: infratemporal) | 92:12 | 101:19 | 97:14 |